DJIA 17,844.96 32.77 0.18%
NASDAQ 5,121.11 18.31 0.36%
S&P 500 2,091.06 1.92 0.09%
market minute promo

Merck & Co., Inc. (NYSE: MRK)

53.70 0.22 (0.41%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

MRK $53.70 0.41%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $53.62
Previous Close $53.48
Daily Range $53.46 - $53.92
52-Week Range $45.69 - $63.62
Market Cap $150.0B
P/E Ratio 14.38
Dividend (Yield) $1.80 (3.4%)
Ex-Dividend Date
Dividend Pay Date
Volume 3,632,535
Average Daily Volume 10,484,073
Current FY EPS $3.56




Drug Makers

Merck & Co., Inc. (MRK) Description

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health. Website:

News & Commentary Rss Feed

How Big Could This Drug Be for Opko Health?

The approval of Varubi could generate meaningful royalty revenue over time.

Bristol-Myers' Opdivo Label Now Includes Renal Cell Cancer

Will Merck (MRK) Stock Be Helped by Dividend Hike?

3 Drugs Stocks Dragging The Industry Down

Noteworthy ETF Outflows: IWB, GE, MRK, PEP

Merrill Lynch 4 Top Pharmaceutical Dividend Stocks To Own For 2016

Dow Movers: MRK, CVX

Benzinga's Top Initiations

10 Dogs Of The Dow Average 15.6% Upsides And 16.78% Net Gains As Of November 20, 2016

This Metric Implies That It Might Be Time to Buy Big Pharma Stocks

This metric, signaling the exodus of a specific type of investor, implies that Big Pharma stocks could be ready to head higher

See More MRK News...

MRK's Top Competitors

MRK $53.70 (0.41%)
Current stock: MRK
JNJ $102.08 (0.04%)
Current stock: JNJ
NVS $86.14 (-0.30%)
Current stock: NVS
RHHBY $33.21 (0.94%)
Current stock: RHHBY